Skye Bioscience, Inc. financial data

Symbol
SKYE on Nasdaq
Location
San Diego, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 10 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 852% % 55%
Debt-to-equity 13% % -40%
Return On Equity -100% % -167%
Return On Assets -89% % -188%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 32,057,461 shares 5.7%
Common Stock, Shares, Outstanding 30,989,046 shares 2.1%
Entity Public Float $224,823,935 USD 1002%
Common Stock, Value, Issued $30,989 USD 2.1%
Weighted Average Number of Shares Outstanding, Basic 39,665,927 shares 2.2%
Weighted Average Number of Shares Outstanding, Diluted 39,665,927 shares 2.2%

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense $16,929,761 USD 8.1%
Operating Income (Loss) $53,934,122 USD -128%
Nonoperating Income (Expense) $2,710,192 USD 14%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $51,223,930 USD -141%
Income Tax Expense (Benefit) $5,400 USD -46%
Net Income (Loss) Attributable to Parent $51,229,330 USD -141%
Earnings Per Share, Basic -1 USD/shares -153%
Earnings Per Share, Diluted -1 USD/shares -153%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $18,441,079 USD -73%
Cash, Cash Equivalents, and Short-term Investments $35,312,308 USD
Other Assets, Current $900,175 USD -66%
Assets, Current $39,924,794 USD -50%
Property, Plant and Equipment, Net $1,033,965 USD -32%
Operating Lease, Right-of-Use Asset $311,620 USD 69%
Other Assets, Noncurrent $53,910 USD 105%
Assets $41,324,289 USD -49%
Accounts Payable, Current $2,825,005 USD 262%
Employee-related Liabilities, Current $920,774 USD 1.9%
Liabilities, Current $8,367,897 USD 49%
Operating Lease, Liability, Noncurrent $120,207 USD 11%
Liabilities $8,488,104 USD 48%
Retained Earnings (Accumulated Deficit) $172,432,523 USD -42%
Stockholders' Equity Attributable to Parent $32,836,185 USD -57%
Liabilities and Equity $41,324,289 USD -49%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $9,185,480 USD -95%
Net Cash Provided by (Used in) Financing Activities $0 USD -100%
Net Cash Provided by (Used in) Investing Activities $12,808,962 USD -1222%
Common Stock, Shares Authorized 100,000,000 shares 0%
Common Stock, Shares, Issued 30,989,046 shares 2.1%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $21,994,442 USD -127%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $18,441,079 USD -76%
Interest Paid, Excluding Capitalized Interest, Operating Activities $126,027 USD 2848%
Deferred Tax Assets, Valuation Allowance $67,743,575 USD 1.9%
Deferred Tax Assets, Gross $67,838,047 USD 2%
Operating Lease, Liability $455,590 USD 87%
Depreciation $27,560 USD -17%
Payments to Acquire Property, Plant, and Equipment $6,312 USD 98%
Lessee, Operating Lease, Liability, to be Paid $503,939 USD 68%
Property, Plant and Equipment, Gross $1,666,265 USD 1101%
Operating Lease, Liability, Current $201,638 USD 143%
Lessee, Operating Lease, Liability, to be Paid, Year Two $202,876 USD 91%
Lessee, Operating Lease, Liability, to be Paid, Year One $215,127 USD 108%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure -27%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $48,349 USD -15%
Lessee, Operating Lease, Liability, to be Paid, Year Three $85,936 USD -5.4%
Deferred Tax Assets, Operating Loss Carryforwards $41,627,022 USD 1.8%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 200,000 shares 0%
Unrecognized Tax Benefits $9,498,441 USD 48%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $177,379 USD 544%
Deferred Tax Assets, Net of Valuation Allowance $94,472 USD 89%
Share-based Payment Arrangement, Expense $8,238,369 USD 21%
Interest Expense $1,324,810 USD 173%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%